2 completed, 1 recruiting, 1 terminated. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 2, Recruiting 1, Terminated 1 |
Follow veverimer: new trials by email Literature Review of veverimer trials Research Report on veverimer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Metabolic Acidosis Veverimer, Placebo - CKD, Metabolic Acidosis | Phase 3 | Recruiting | Renibus Therapeutics, Inc. | 150 | 2026-01-13 | 2026-10-23 |
| Evaluation of Effect of TRC101 on Progression of Chronic Kidney Disease in Subjects With Metabolic Acidosis TRC101, Placebo - Metabolic Acidosis, Chronic Kidney Disease | Phase 3 | Terminated | Tricida, Inc. | 1480 | 2018-11-20 | 2022-10-14 |
| Long-term Safety Extension to Study TRCA-301 TRC101, Placebo - Metabolic Acidosis | Phase 3 | Completed | Tricida, Inc. | 196 | 2017-12-20 | 2021-10-22 |
| Evaluation of TRC101 in Subjects With Metabolic Acidosis Associated With Chronic Kidney Disease TRC101, Placebo - Metabolic Acidosis | Phase 3 | Completed | Tricida, Inc. | 217 | 2017-09-26 | 2021-04-26 |
Acidosis (4) · Kidney Diseases (2) · Renal Insufficiency, Chronic (1)
Tricida, Inc. (3) · Renibus Therapeutics, Inc. (1)
United States (4) · Bulgaria (3) · Georgia (3) · Hungary (3) · Serbia (3) · Ukraine (3) · Slovenia (2) · Albania (1) · Argentina (1) · Armenia (1) · Australia (1) · Belarus (1) · Belgium (1) · Brazil (1) · Canada (1)
PMID 30857647, PMID 31248662, PMID 34009141, PMID 35216581, PMID 38261535
2016 (1), 2018 (1)